Francesca Barone Candel Therapeutics, Inc. (CADL) insider trading activity
Francesca Barone is Chief Scientific Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 100,809 shares of CADL, which is worth approximately $690,541. The most recent transaction as insider was on Jun 25, 2025, when has been sold 4,282 shares (Common Stock) at a price of $4.67 per share, resulting in proceeds of $19,996. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
101K
4.44%
3M change
36.98%
12M change
Total Value Held
$690,541
Francesca Barone Transaction History
FB
Francesca Barone
Chief Scientific Officer
Needham, MA